CelluComp is a Scottish company located in Fife, near Edinburgh. Its team of scientists and business professionals work on the development and commercialisation of sustainable materials. The company's principal product is Curran®, a material based on nanocellulose fibers extracted from root vegetables, primarily sugar beet pulp, which is a by-product of the sugar industry. Curran® offers exceptional mechanical and rheological properties for numerous applications, such as paints and coatings, inks, personal care, home care, paper, food, concrete, drilling fluids, composites and other potential applications.
The Sofinnova Capital Strategy acts as a founding and lead investor in early-stage biopharma and medtech start-ups focusing on groundbreaking therapeutic technologies.
The MD Start Strategy is Sofinnova’s in-house medtech accelerator. The team’s hands-on entrepreneurial expertise contributes to the platform's global leadership in company building.
The Sofinnova Crossover Strategy supports ground-breaking innovations in later-stage biotech and medtech companies, enabling ambitious life sciences companies to reach their full potential.
Our Industrial Biotech Strategy seeks early-stage investments that will have a positive impact on sustainability in the chemicals, agriculture, food and materials sectors.
The Sofinnova Telethon Strategy seeks early-stage projects to bring the best Italian science to the world stage.